Muresanu, MD, PhD Department of Neurosciences and RoNeuro Institute Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania Professor Dafin Muresanu has been a principal investigator for multiple large-scale Cerebrolysin clinical trials since the early 2000s, leading landmark studies that have shaped understanding of this peptide preparations potential in stroke and traumatic brain injury
Specifically, in non-diabetic females with a BMI exceeding 35 kg/m 2 , prenatal administration of metformin resulted in reduced maternal weight gain without impacting newborn birth weight (Syngelaki et al., 2016)
Published August 9, 2024
We treat data protection as a baseline requirement
Belkoff Nutritional guidance and support No contracts, cancel anytime $250 per month, starting dose Compounded tirzepatide medication Personalized dosing protocol from Dr
It changes the pattern of them